Correlation Between Willow Biosciences and Pharmagreen Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Willow Biosciences and Pharmagreen Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Willow Biosciences and Pharmagreen Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Willow Biosciences and Pharmagreen Biotech, you can compare the effects of market volatilities on Willow Biosciences and Pharmagreen Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Willow Biosciences with a short position of Pharmagreen Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Willow Biosciences and Pharmagreen Biotech.

Diversification Opportunities for Willow Biosciences and Pharmagreen Biotech

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between Willow and Pharmagreen is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Willow Biosciences and Pharmagreen Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmagreen Biotech and Willow Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Willow Biosciences are associated (or correlated) with Pharmagreen Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmagreen Biotech has no effect on the direction of Willow Biosciences i.e., Willow Biosciences and Pharmagreen Biotech go up and down completely randomly.

Pair Corralation between Willow Biosciences and Pharmagreen Biotech

Assuming the 90 days horizon Willow Biosciences is expected to generate 14.23 times less return on investment than Pharmagreen Biotech. But when comparing it to its historical volatility, Willow Biosciences is 2.02 times less risky than Pharmagreen Biotech. It trades about 0.01 of its potential returns per unit of risk. Pharmagreen Biotech is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  0.07  in Pharmagreen Biotech on September 4, 2024 and sell it today you would earn a total of  0.11  from holding Pharmagreen Biotech or generate 157.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.6%
ValuesDaily Returns

Willow Biosciences  vs.  Pharmagreen Biotech

 Performance 
       Timeline  
Willow Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Willow Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Willow Biosciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Pharmagreen Biotech 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmagreen Biotech are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile fundamental drivers, Pharmagreen Biotech demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Willow Biosciences and Pharmagreen Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Willow Biosciences and Pharmagreen Biotech

The main advantage of trading using opposite Willow Biosciences and Pharmagreen Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Willow Biosciences position performs unexpectedly, Pharmagreen Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmagreen Biotech will offset losses from the drop in Pharmagreen Biotech's long position.
The idea behind Willow Biosciences and Pharmagreen Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device